Poorly differentiated Sertoli–Leydig tumor with heterologous, high-grade, sarcomatoid features: A case report

• Treatment of sex-cord stromal tumors with carboplatin and taxane is both feasible and safe. • FOXL2 mutations account for approximately 50% of these tumors. • Carboplatin and taxane may afford a favorable outcome.

Detalles Bibliográficos
Autores principales: Brightwell, Rachel, Grzankowski, Kassondra, Kasznica, John, Frederick, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688826/
https://www.ncbi.nlm.nih.gov/pubmed/26793762
http://dx.doi.org/10.1016/j.gore.2015.08.001
_version_ 1782406754361933824
author Brightwell, Rachel
Grzankowski, Kassondra
Kasznica, John
Frederick, Peter J.
author_facet Brightwell, Rachel
Grzankowski, Kassondra
Kasznica, John
Frederick, Peter J.
author_sort Brightwell, Rachel
collection PubMed
description • Treatment of sex-cord stromal tumors with carboplatin and taxane is both feasible and safe. • FOXL2 mutations account for approximately 50% of these tumors. • Carboplatin and taxane may afford a favorable outcome.
format Online
Article
Text
id pubmed-4688826
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-46888262016-01-20 Poorly differentiated Sertoli–Leydig tumor with heterologous, high-grade, sarcomatoid features: A case report Brightwell, Rachel Grzankowski, Kassondra Kasznica, John Frederick, Peter J. Gynecol Oncol Rep Case Report • Treatment of sex-cord stromal tumors with carboplatin and taxane is both feasible and safe. • FOXL2 mutations account for approximately 50% of these tumors. • Carboplatin and taxane may afford a favorable outcome. Elsevier 2015-08-13 /pmc/articles/PMC4688826/ /pubmed/26793762 http://dx.doi.org/10.1016/j.gore.2015.08.001 Text en © 2015 The Authors. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Brightwell, Rachel
Grzankowski, Kassondra
Kasznica, John
Frederick, Peter J.
Poorly differentiated Sertoli–Leydig tumor with heterologous, high-grade, sarcomatoid features: A case report
title Poorly differentiated Sertoli–Leydig tumor with heterologous, high-grade, sarcomatoid features: A case report
title_full Poorly differentiated Sertoli–Leydig tumor with heterologous, high-grade, sarcomatoid features: A case report
title_fullStr Poorly differentiated Sertoli–Leydig tumor with heterologous, high-grade, sarcomatoid features: A case report
title_full_unstemmed Poorly differentiated Sertoli–Leydig tumor with heterologous, high-grade, sarcomatoid features: A case report
title_short Poorly differentiated Sertoli–Leydig tumor with heterologous, high-grade, sarcomatoid features: A case report
title_sort poorly differentiated sertoli–leydig tumor with heterologous, high-grade, sarcomatoid features: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688826/
https://www.ncbi.nlm.nih.gov/pubmed/26793762
http://dx.doi.org/10.1016/j.gore.2015.08.001
work_keys_str_mv AT brightwellrachel poorlydifferentiatedsertolileydigtumorwithheterologoushighgradesarcomatoidfeaturesacasereport
AT grzankowskikassondra poorlydifferentiatedsertolileydigtumorwithheterologoushighgradesarcomatoidfeaturesacasereport
AT kasznicajohn poorlydifferentiatedsertolileydigtumorwithheterologoushighgradesarcomatoidfeaturesacasereport
AT frederickpeterj poorlydifferentiatedsertolileydigtumorwithheterologoushighgradesarcomatoidfeaturesacasereport

Ejemplares similares